Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:24 PM ET 10-Q
Financial Results Canary Staked SUI ETF SUIS

Canary Staked SUI ETF Q3 2026 Results: Net Income $13.2M

As of September 30, 2026, the Canary Staked SUI ETF held net assets of $33,887,152, primarily consisting of SUI cryptocurrency valued at $33,936,747. For the period from its inception on February 17, 2026, through September 30, 2026, the Trust reported a net increase in net assets from operations of $5,766,462, driven largely by $5,780,708 in unrealized appreciation on its SUI holdings.

Key figure
Net income $13.2M
5:23 PM ET 10-Q
Financial Results Cingulate Inc. CING

Cingulate Q3 2026 Results: Net Loss of $7.73M, Loss Widens

Cingulate Inc. reported a net loss of $22.9 million for the nine months ended September 30, 2026, as it continues to develop its ADHD drug candidates CTx-1301 and CTx-1302. Despite receiving a Complete Response Letter from the FDA for CTx-1301 in June 2026, the company strengthened its liquidity position to $23.2 million in cash through significant financing activities, including at-the-market offerings and private placements.

Key figure
Net loss $7.73M
5:23 PM ET 10-Q
Financial Results Canary Marinade Solana ETF SOLC

Canary Marinade Solana ETF Q3 2026 Results: Net Income $706K

For the nine months ended September 30, 2026, the Trust incurred $5,864 in Sponsor Fees, with $3,202 waived under a fee waiver that expired on June 30, 2026. The Trust saw net share creation activity of 90,000 shares valued at approximately $2.07 million during the first nine months of 2026.

Key figure
Net income $706K
5:23 PM ET Form 4
Insider Selling U-Haul Holding Co UHAL

U-Haul Holding 10% Owner Mark V. Shoen Sells $2.28M of Stock

Mark V. Shoen, 10% Owner, sold 46,000 shares of U-Haul Holding Co at $49.35 to $49.67 a share (average $49.51) in 2 transactions, worth $2.28M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 103,196 (-18.2%).

Value
$2.28M
Shares
46,000
Average price
$49.51
Role
10% Owner
Holding change
-18.2%
Trade date
Nov 11, 2026 to Nov 12, 2026
5:23 PM ET Form 4
Insider Selling Bbb Foods Inc TBBB

Bbb Foods Chairman & CEO Kamal Anthony Hatoum Sells $4.1M of Stock

Kamal Anthony Hatoum, Chairman & CEO, sold 60,000 shares of Bbb Foods Inc at $68.32 a share, worth $4.1M in total on Nov 13, 2026. Shares held after the trade: 15,943,914 (-0.4%).

Value
$4.1M
Shares
60,000
Price
$68.32
Role
Chairman & CEO
Holding change
-0.4%
Trade date
Nov 13, 2026
5:22 PM ET 8-K
Loan & Debt Western Union CO WU

Western Union $800M Debt Financing with Bank of America, N.A.

Western Union borrowed $800 million under its existing delayed draw term loan credit agreement, exhausting the facility's commitments. The company intends to use the proceeds to refinance and repay in full an existing $800 million term loan scheduled to mature in December 2027. This refinancing effectively replaces the 2024 Term Loan Agreement with the newer Term Loan Agreement facility.

Value
$800M
Counterparty
Bank of America, N.A.
5:22 PM ET Form 4
Insider Selling OneSpan Inc. OSPN

OneSpan Insider Michael J. McConnell Sells $466K of Stock

Michael J. McConnell sold 20,000 shares of OneSpan Inc. at $22.00 to $24.56 a share (average $23.31) in 7 transactions, worth $466K in total between Nov 3, 2026 and Nov 9, 2026. Shares held after the trade: 70,398 (-6.6%).

Value
$466K
Shares
20,000
Average price
$23.31
Holding change
-6.6%
Trade date
Nov 3, 2026 to Nov 9, 2026
5:22 PM ET 8-K
Loan & Debt 3D Systems Corp DDD

3D Systems $85M Debt Financing with U.S. Bank Trust Company, National Association

3D Systems completed a debt exchange, issuing $85 million in 3.30% Convertible Senior Notes due 2031 in exchange for all of its outstanding 5.875% Convertible Senior Secured Notes due 2030. As part of the transaction, the company also paid $20 million in cash and issued approximately 13.5 million shares of common stock to the participating noteholders. The new 2031 notes are senior unsecured obligations with an initial conversion price of approximately $3.43 per share.

Value
$85M
Counterparty
U.S. Bank Trust Company, National Association
Term
through April 2031
5:22 PM ET 8-K
Leadership Change Navient Holdings, Inc. NAVI

Navient Holdings Leadership Change

Frederick Arnold, a member of the Board of Directors of Navient Holdings, Inc., voluntarily retired from the Board effective November 11, 2026. The company stated that his departure was not the result of any disagreement with the company.

5:22 PM ET 8-K
Loan & Debt Polomar Health Services, Inc. PMHS

Polomar Health Services Debt Financing Update with Island 40 Group, LLC

Polomar Health Services executed a $450,000 promissory note and loan agreement with Island 40 Group, LLC to settle outstanding commissions owed for sales and distribution services. The note bears an initial 10% interest rate and is guaranteed by the company's wholly owned subsidiary, Polomar Specialty Pharmacy, LLC. The debt matures on March 31, 2027, and represents the formalization of a direct financial obligation for past services.

Counterparty
Island 40 Group, LLC
Term
through March 31, 2027
5:22 PM ET 10-Q
Financial Results Canary Litecoin ETF LTCC

Canary Litecoin ETF Q3 2026 Results: Net Income $3.11M

Canary Litecoin ETF reported net assets of $14.19 million as of September 30, 2026, a significant increase from $6.96 million at the end of 2025, driven primarily by $8.30 million in net capital share transactions. The Trust experienced a net decrease in net assets from operations of $1.07 million for the nine months ended September 30, 2026, as realized losses on Litecoin holdings outweighed unrealized appreciation.

Key figure
Net income $3.11M
5:21 PM ET 10-Q
Financial Results 21Shares Hyperliquid Staking ETF THYP

21Shares Hyperliquid Staking ETF Q1 2026 Results: Net Income $22.1M

For the quarter ended September 30, 2026, the Trust's NAV per share increased from $37.86 to $51.29, driven by a total return of 35.99%. The Trust held 1,023,491 HYPE tokens valued at approximately $90.8 million, despite a net redemption of 110,000 shares during the period.

Key figure
Net income $22.1M
5:21 PM ET 8-K
Leadership Change IonQ, Inc. IONQ

IonQ Leadership Change

IonQ appointed Gary Merrill as Chief Financial Officer and Thomas A. Austin as Chief Accounting Officer, effective December 2026 and immediately, respectively. Merrill succeeds Inder M. Singh, who is stepping down from his roles at the company. The transition aims to strengthen IonQ's public company finance expertise as it scales its quantum platform and foundry operations.

5:21 PM ET 10-Q
Financial Results CSB Financial Inc. CSBA

CSB Financial Q3 2026 Results: Net Loss of $119K

CSB Financial Inc. completed its mutual-to-stock conversion in 2026, raising $12.1 million in net proceeds and issuing 1,402,935 shares. For the nine months ended September 30, 2026, net income was $136,612, down from $325,585 in the prior year, primarily due to a $375,000 one-time charitable contribution related to the conversion.

Key figure
Net loss $119K
5:21 PM ET 10-Q
Financial Results CoJax Oil & Gas Corp CJAX

CoJax Oil & Gas Q3 2026 Results: Turns Profitable, Net Income $2.9K

CoJax Oil & Gas Corp reported a net income of $2,895 for the quarter ended September 30, 2026, a significant improvement from a net loss of $157,705 in the prior year period. Despite achieving profitability in the last two quarters, management expressed substantial doubt about the company's ability to continue as a going concern due to insufficient profits to support business expansion.

Key figure
Net income $2.9K
5:20 PM ET 8-K
Executive Compensation Dolby Laboratories, Inc. DLB

Dolby Laboratories Executive Compensation

Dolby Laboratories adopted the 2027 Executive Bonus Plan, a cash-based incentive program where CEO Marc Whitten is eligible for a target bonus of 100% of his base salary. The company also approved a new Executive Severance Policy for senior leadership, providing standardized cash severance and benefits for qualified terminations outside of a change-in-control period.

Term
fiscal 2027
5:20 PM ET Form 4
Insider Selling PG&E Corp PCG

PG&E Insider Mark E. Ferguson III Sells $115K of Stock

Mark E. Ferguson III sold 8,675 shares of PG&E Corp at $13.22 a share, worth $115K in total on Nov 11, 2026. Shares held after the trade: 2,000 (-81.3%).

Value
$115K
Shares
8,675
Price
$13.22
Holding change
-81.3%
Trade date
Nov 11, 2026
5:20 PM ET 10-Q
Financial Results Enhanced Group Inc. ENHA

Enhanced Group Q3 2026 Results: Net Loss of $13.5M, Loss Widens

Enhanced Group Inc. is an emerging growth company focused on enhancement-based athletic competition and the Live Enhanced platform. The filing highlights significant risks including a limited operating history, minimal revenues, and a need for additional capital to continue as a going concern following its recent business combination.

Key figure
Net loss $13.5M
5:20 PM ET 8-K
Other 8-K Filing Panamera Holdings Corp PHCI

Panamera Holdings Other 8-K Filing

Panamera Holdings Corp announced that its previously issued financial statements for the fiscal year ended July 31, 2025, can no longer be relied upon. The non-reliance is due to an unreported employment agreement and a resulting lawsuit that impacted the company's financial reporting. The company is currently in the process of restating these financial statements and plans to file an amended Annual Report on Form 10-K as soon as practicable.

5:19 PM ET 8-K
Financial Results Cingulate Inc. CING

Cingulate Financial Results

Cingulate reported Q3 2026 financial results, highlighting a cash position of $23.2 million and progress on its CTx-1301 NDA resubmission. The company has substantially completed manufacturing work to address FDA CMC requests and expects to resubmit the NDA between December 2026 and January 2027. Additionally, the company added Maxim Group LLC as a sales agent to its existing $100 million ATM equity offering program.

Term
Q3 2026

“With the manufacturing work substantially complete, we are now finalizing the data and documentation needed to resubmit the NDA for CTx-1301, and we expect to do so by January 2027, potentially sooner.”

Shane J. Schaffer, Chairman and CEO

“Importantly, the FDA’s Complete Response Letter did not raise any concerns about the clinical safety or efficacy of CTx-1301. We thank our shareholders for their patience and continued support as we work to bring this treatment to patients with ADHD.”

Shane J. Schaffer, Chairman and CEO
5:19 PM ET 10-Q
Financial Results Amaze Holdings, Inc. AMZE

Amaze Holdings Q3 2026 Results: Net Loss of $22.2M, Loss Widens

Amaze Holdings, Inc. reported a significant net loss of $32.3 million for the nine months ended September 30, 2026, primarily driven by a $17.7 million impairment of intangible assets. Revenues declined sharply to $0.47 million in the third quarter compared to $1.25 million in the prior year period, while the company's stockholders' equity shifted from a surplus of $9.8 million to a deficit of $8.2 million.

Key figure
Net loss $22.2M
5:18 PM ET 10-K
Financial Results Edgewell Personal Care Co EPC ▶ Call

Edgewell Personal Care FY 2026 Results: Net Loss of $51.7M

Edgewell Personal Care Co. is focused on its 'Sustainable Care' strategy, targeting reductions in petroleum-based plastics, greenhouse gas emissions, and waste diversion. The company reported approximately 6,500 employees as of September 30, 2026, and continues to manage significant regulatory compliance obligations under the FDA, CPSC, TSCA, and REACH frameworks.

Key figure
Net loss $51.7M
5:18 PM ET 8-K12B
Other 8-K Filing Versa Bancorp VRSA

Versa Bancorp Other 8-K Filing

VersaBank completed a corporate reorganization to establish Versa Bancorp, a Delaware corporation, as its new U.S. bank holding company. Each outstanding common share of VersaBank was exchanged for one share of Versa Bancorp common stock, which will trade on Nasdaq and the TSX under the new ticker 'VRSA' starting around November 17, 2026.

5:18 PM ET 10-Q
Financial Results Pasithea Therapeutics Corp. KTTA

Pasithea Therapeutics Q3 2026 Results: Net Loss of $6.58M, Loss Widens

Pasithea Therapeutics Corp. reported a net loss of $14.7 million for the nine months ended September 30, 2026, driven by a significant increase in research and development expenses to $11.1 million. The company maintained a cash position of $41.2 million as of the end of the period, down from $55.2 million at the start of the year.

Key figure
Net loss $6.58M
5:18 PM ET 10-Q
Financial Results Health In Tech, Inc. HIT

Health In Tech Q3 2026 Results: Net Loss of $7.07M

For the nine months ended September 30, 2026, Health In Tech, Inc. reported total revenues of $23.4 million, a decrease from $25.8 million in the prior year period. The company experienced a significant shift in its financial position, moving from a retained earnings balance of $5.2 million at the end of 2025 to an accumulated deficit of $5.9 million as of September 30, 2026.

Key figure
Net loss $7.07M
5:18 PM ET 8-K
Nasdaq/NYSE Compliance Notice Flux Power Holdings, Inc. FLUX

Flux Power Holdings Nasdaq/NYSE Compliance Notice

Flux Power Holdings received a deficiency notice from Nasdaq on November 9, 2026, for failing to maintain the minimum $2.5 million stockholders' equity requirement. The company has until December 24, 2026, to submit a plan to regain compliance and is also working to meet an extended December 4 deadline for a $4.0 million equity raise required by its lender, Gibraltar Business Capital.

Counterparty
Nasdaq
Term
45 days
5:18 PM ET Form 4
Insider Selling Globalstar, Inc. GSAT

Globalstar VP, Finance & Operations Timothy Evan Taylor Sells $11.2M of Stock

Timothy Evan Taylor, VP, Finance & Operations, sold 129,996 shares of Globalstar, Inc. at $86.16 to $86.38 a share (average $86.29) in 3 transactions, worth $11.2M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 80,244 (-52.9%).

Value
$11.2M
Shares
129,996
Average price
$86.29
Role
VP, Finance & Operations
Holding change
-52.9%
Trade date
Nov 11, 2026 to Nov 12, 2026
5:18 PM ET 10-Q
Financial Results Nuo Therapeutics, Inc. AURX

Nuo Therapeutics Q3 2026 Results: Net Loss of $425K, Loss Narrows

Nuo Therapeutics reported a significant revenue increase to $4.9 million for the nine months ended September 30, 2026, compared to $2.2 million in the prior year, driven by product sales and distribution fees. Despite the growth, the company remains in a stockholders' deficit and continues to rely on debt financing, including $1.175 million in net proceeds from notes payable issued during 2026.

Key figure
Net loss $425K
5:17 PM ET 8-K
Leadership Change Douglas Elliman Inc. DOUG

Douglas Elliman Leadership Change

Douglas Elliman announced a major leadership transition including the retirement of CFO James B. Kirkland III and the departure of General Counsel Bradley H. Brodie. Heather Capriola, previously VP of Finance, has been appointed as the new Executive Vice President, Treasurer, and CFO. The departing executives will receive severance packages including cash payments and accelerated vesting of restricted shares.

5:17 PM ET 8-K
Nasdaq/NYSE Compliance Notice Datavault AI Inc. DVLT

Datavault AI Nasdaq/NYSE Compliance Notice

Datavault AI received a delisting notice from Nasdaq due to non-compliance with the $1.00 minimum bid price requirement and a closing bid price below $0.10 for ten consecutive business days. Trading on Nasdaq will be suspended effective November 17, 2026, at which point the company expects its common stock to begin trading on the OTC Markets. The company intends to request a hearing before the Nasdaq Hearings Panel to present a compliance plan and seek an extension to maintain its listing.

Counterparty
Nasdaq

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.